← The Wire
DYNNasdaq
Dyne Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1818794
Dyne Therapeutics develops targeted therapeutics for genetically driven neuromuscular diseases using its FORCE platform
red 8-K · 90d
$3.01B
Market cap
$21.26
Last close
+1.5%
1D
+1.9%
5D
2.2M
Volume
Price · last 39 sessions+20.0%
May 4L $15.92 · H $21.26Jun 29
126
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 22, 20268-KMaterial Agreement · New Debt / ObligationJun 17, 20268-KShareholder VoteJun 8, 20268-KReg FD Disclosure · Company UpdateJun 3, 20268-KResults of OperationsMay 11, 202610-Q10-QMay 11, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KResults of OperationsMar 2, 202610-K10-KMar 2, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KExecutive ChangeDec 23, 2025424B5424B5Dec 10, 20258-KMaterial Agreement · Company UpdateDec 10, 2025424B5424B5Dec 8, 20258-KNew Debt / ObligationDec 8, 20258-KReg FD Disclosure · Company UpdateDec 8, 20258-KResults of OperationsNov 5, 202510-Q10-QNov 5, 20258-KExecutive ChangeOct 2, 20258-KReg FD Disclosure · Company UpdateAug 4, 20258-KResults of OperationsJul 28, 202510-Q10-QJul 28, 2025424B5424B5Jul 1, 20258-KMaterial Agreement · Company UpdateJul 1, 2025424B5424B5Jun 30, 20258-KMaterial Agreement · New Debt / ObligationJun 30, 20258-KReg FD Disclosure · Company UpdateJun 17, 20258-KShareholder VoteJun 5, 20258-KResults of OperationsMay 8, 202510-Q10-QMay 8, 2025DEFA14ADEFA14AApr 15, 2025DEF 14ADEF 14AApr 15, 20258-KExecutive ChangeMar 20, 20258-KResults of OperationsFeb 27, 202510-K10-KFeb 27, 20258-KResults of Operations · Reg FD DisclosureJan 10, 2025SC 13GSC 13GNov 14, 2024SC 13GSC 13GNov 12, 20248-KCompany UpdateNov 12, 2024424B5424B5Nov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QNov 12, 20248-KExecutive Change · Reg FD DisclosureSep 3, 20248-KResults of OperationsAug 12, 202410-Q10-QAug 12, 20248-KShareholder VoteMay 24, 2024424B5424B5May 22, 20248-KMaterial Agreement · Company UpdateMay 22, 2024424B5424B5May 20, 20248-KReg FD Disclosure · Company UpdateMay 20, 20248-KResults of OperationsMay 2, 202410-Q10-QMay 2, 2024DEFA14ADEFA14AApr 5, 2024DEF 14ADEF 14AApr 5, 2024SC 13GSC 13GApr 4, 20248-KExecutive ChangeMar 25, 20248-KResults of OperationsMar 5, 202410-K10-KMar 5, 2024SC 13GSC 13GJan 29, 2024SC 13GSC 13GJan 19, 2024424B5424B5Jan 5, 20248-KMaterial Agreement · Company UpdateJan 5, 20248-KCompany UpdateJan 4, 2024424B5424B5Jan 3, 20248-KReg FD Disclosure · Company UpdateJan 3, 20248-KResults of OperationsOct 30, 202310-Q10-QOct 30, 20238-KResults of OperationsAug 3, 202310-Q10-QAug 3, 20238-KExecutive Change · Shareholder VoteMay 25, 20238-KResults of OperationsMay 11, 202310-Q10-QMay 11, 2023DEFA14ADEFA14AApr 7, 2023DEF 14ADEF 14AApr 7, 20238-KReg FD DisclosureMar 10, 20238-KResults of OperationsMar 2, 202310-K10-KMar 2, 2023SC 13GSC 13GFeb 9, 2023SC 13GSC 13GFeb 8, 2023
Insider Activity
In the 90 days to Mar 11, 2026: 1 insider bought $84K · 4 sold $15.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Kersten DirkDirector | Sell | 129,672 | $19.52 | $2.5M |
| Mar 11, 2026 | Posner Brian SDirector | Buy | 2,000 | $19.35 | $39K |
| Mar 10, 2026 | Kersten DirkDirector | Sell | 281,858 | $19.80 | $5.6M |
| Mar 10, 2026 | Kersten DirkDirector | Sell | 219,758 | $19.33 | $4.2M |
| Mar 10, 2026 | Kersten DirkDirector | Sell | 9,482 | $18.21 | $173K |
| Mar 9, 2026 | Kersten DirkDirector | Sell | 177,690 | $17.72 | $3.1M |
| Mar 6, 2026 | Posner Brian SDirector | Buy | 3,000 | $15.06 | $45K |
| Mar 5, 2026 | Cox JohnCEO & President | Sell | 2,732 | $14.90 | $41K |
| Mar 5, 2026 | Kerr DouglasChief Medical Officer | Sell | 904 | $14.90 | $13K |
| Mar 5, 2026 | Friedl-Naderer JohannaChief Commercial Officer | Sell | 148 | $14.90 | $2K |
| Dec 5, 2025 | Cox JohnCEO & President | Sell | 2,662 | $20.72 | $55K |
| Dec 5, 2025 | Kerr DouglasChief Medical Officer | Sell | 880 | $20.72 | $18K |
| Dec 5, 2025 | Friedl-Naderer JohannaChief Commercial Officer | Sell | 144 | $20.72 | $3K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance